Literature DB >> 11835012

Successful use of recombinant activated factor VII for trauma-associated hemorrhage in a patient without preexisting coagulopathy.

Patricia A O'Neill1, Martin Bluth, Elizabeth S Gloster, Devdas Wali, Soula Priovolos, Thérèse M DiMaio, David W Essex, Charles A Catanese, Robert A Strauss.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11835012     DOI： 10.1097/00005373-200202000-00034

Source DB:  PubMed          Journal:  J Trauma        ISSN： 0022-5282


× No keyword cloud information.
  11 in total

1.  Refractory bleeding following major surgery of a giant sacrococcygeal teratoma in a premature infant: successful use of recombinant factor VIIa.

Authors:  Monika Girisch; Ralf Rauch; Roman Carbon; Thomas Habash; Michael Hofbeck
Journal:  Eur J Pediatr       Date:  2004-01-10       Impact factor: 3.183

Review 2.  Recombinant factor VIIa: a review on its clinical use.

Authors:  Massimo Franchini
Journal:  Int J Hematol       Date:  2006-02       Impact factor: 2.490

Review 3.  The emerging role of recombinant-activated factor VII in neurocritical care.

Authors:  Matthew E Fewel; Paul Park
Journal:  Neurocrit Care       Date:  2004       Impact factor: 3.210

4.  Perioperative use of recombinant factor VII to prevent intraoperative aneurysm rupture in high risk patients: a preliminary safety evaluation.

Authors:  Eric S Nussbaum; Tariq M Janjua; Archie Defillo; Penny Sinner; Andrea Zelensky
Journal:  Neurocrit Care       Date:  2008-09-26       Impact factor: 3.210

5.  Hemostatic and neuroprotective effects of human recombinant activated factor VII therapy after traumatic brain injury in pigs.

Authors:  Jun Zhang; Robert F Groff; Xiao-Han Chen; Kevin D Browne; Jason Huang; Eric D Schwartz; David F Meaney; Victoria E Johnson; Sherman C Stein; Rasmus Rojkjaer; Douglas H Smith
Journal:  Exp Neurol       Date:  2008-01-05       Impact factor: 5.330

Review 6.  Acute resuscitation of the unstable adult trauma patient: bedside diagnosis and therapy.

Authors:  Andrew W Kirkpatrick; Chad G Ball; Scott K D'Amours; David Zygun
Journal:  Can J Surg       Date:  2008-02       Impact factor: 2.089

Review 7.  Recombinant activated factor VIIa and hemostasis in critical care: a focus on trauma.

Authors:  Alicia M Mohr; John B Holcomb; Richard P Dutton; Jacques Duranteau
Journal:  Crit Care       Date:  2005-10-07       Impact factor: 9.097

Review 8.  Mechanistic implications for the use and monitoring of recombinant activated factor VII in trauma.

Authors:  Anthony E Pusateri; Myung S Park
Journal:  Crit Care       Date:  2005-10-07       Impact factor: 9.097

9.  Successful use of recombinant activated factor VII for postoperative associated haemorrhage: a case report.

Authors:  Konstantinos Vlachos; Fotis Archontovasilis; Artemisia Papadima; Dimitrios Maragiannis; Stavros Aloizos; Emmanuel Lagoudianakis; Ioannis G Dalianoudis; Nikolaos Koronakis; John Chrysikos; Spyros Zaravinos; Andreas Manouras
Journal:  Cases J       Date:  2008-11-29

10.  Effect of haemodilution, acidosis, and hypothermia on the activity of recombinant factor VIIa (NovoSeven).

Authors:  D Viuff; B Lauritzen; A E Pusateri; S Andersen; R Rojkjaer; P I Johansson
Journal:  Br J Anaesth       Date:  2008-06-18       Impact factor: 9.166
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.